跳至主要内容
临床试验/NCT02941484
NCT02941484Unknown不适用

A Prospective, Randomized Trial of Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS

Xuzhou Medical University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
100
试验地点
1
主要终点
Tolerance of Oral Intake

研究概览

简要总结

Early oral intake after Pancreaticoduodenectomy is recommended strongly according to the ERAS guideline, which was based on studies in patients with gastrointestinal cancer, mainly colorectal and gastric. Specific clinical study on early oral intake after PD is very limited. inadequate nutritional intake was significantly associated with a high incidence of postoperative complications. Therefore, the present study is aim to evaluate the tolerance, safety, and efficacy in the patients undergoing PD in the age of ERAS.

详细描述

Enhanced Recovery After Surgery (ERAS) is an interdisciplinary, multimodal concept and has become an important focus of Pancreaticoduodenectomy procedures following universal accepted and practice in gastrointestinal and colorectal surgeries. Early oral diet without restrictions after operation is recommended strongly according to ERAS guideline. However, several studies demonstrated that only half validated the true practice of the postoperative oral diet. Furthermore, Oral intake tolerance after PD is controversial. Only 23% of patients were able to take solid food at day 3. It appears that adequate nutritional intake only via oral diet is a severe challenge. Besides, Studies showed that insufficient amount of dietary intake was significantly associated with extended duration of postoperative hospitalization and parenteral nutrition. Importantly, Specific clinical study on early oral intake after PD is very limited. Therefore, the present study is aim to evaluate the tolerance, safety, and efficacy in the patients undergoing PD in the age of ERAS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Periampullar carcinoma
  • •Pancreaticoduodenectomy
  • •ERAS protocol implemented

排除标准

  • •Preoperative Radiotherapy/chemotherapy
  • •Unresectable primary cancer
  • •Palliative surgery
  • •New York Heart Association class>3

研究组 & 干预措施

1 early oral intake

Experimental

early oral intake since postoperative day 1.

干预措施: early oral intake (Procedure)

2 jejunostomy tube feeding (JTF)

Experimental

jejunostomy tube feeding (JTF) was carried out after PD

干预措施: jejunostomy tube feeding (JTF) (Procedure)

结局指标

主要结局

Tolerance of Oral Intake

时间窗: postoperative 1 to 7day

the amount of oral intake is recorded, including clear fluids, soft and solid food.

次要结局

  • morbidity rate(postoperative 1day to discharge, up to 8 weeks)
  • length of stay(postoperative 1day to discharge,up to 8 weeks)
  • Readmission rate(30 days after discharge)
  • Hospital costs(postoperative 1day to discharge,up to 8 weeks)
  • Albumin(postoperative 30d)
  • weight(postoperative 30d)
  • height(postoperative 30d)

研究者

发起方
Xuzhou Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zheng Chen

the director of general surgery;

Xuzhou Medical University

研究点 (1)

Loading locations...

相似试验